This includes baseline labs, follow-up testing, vital sign monitoring, and dose adjustments based on the patients individual response
A phase 2 trial assessing different doses of bimagrumab (up to 30 mg/kg) in combination with semaglutide as obesity treatment is ongoing (NCT05616013)
That said, when we attempt to pharmacologically interfere with, preserve, or augment the bodys innate physiological processes, there are bound to be side effects and adverse events
However, there are examples of drugs being withdrawn from the market as more long-term data comes to light
Influences brain regions involved in appetite control
At Arla Foods Ingredients, weve incorporated our speciality whey proteins in a series of functional dairy concepts to demonstrate the potential